Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

The European Union has launched the Choose Europe for Science initiative and pledged €500 million in funding to attract US ...

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...

Worldwide adult obesity has more than doubled since 1990, and, even more shockingly, adolescent obesity has quadrupled, becoming an ever-growing health threat. The latest figures from the World Health ...

Gene therapy represents a transformative approach in modern medicine, with the potential to address and cure a wide array of genetic disorders. By introducing, modifying, or repairing genetic material ...

Aplagon is developing novel treatments for thromboinflammatory diseases. Its lead candidate, APAC, is a first-in-class therapeutic designed to act locally at sites of vascular injury by combining ...

The biotech industry thrives on partnerships, as they help to drive innovation through the sharing of knowledge, expertise, and resources. There are many different types of biotech partnerships on ...